NCNED Researcher Mr Tanoj Singh presented the latest diffusion MRI findings in #MECFS & #longCOVID at the Young EMERG Symposium 2026, held on 25 - 26 May at Wellcome Genome Campus, Cambridge, UK. His research showcased preliminary evidence of brain tissue microstructural....
Chandi Magawa & the NCNED team are thrilled to announce the submission of a novel & innovative PhD thesis that pushed the boundaries of ion channel research in #MECFS & #longCOVID. Congratulations Chandi!! #griffithuni, #griffithhealth
For 14 years, NCNED has remained unwavering in its commitment to patients & their progress. In 2026, we continue to support #MECFS patients by promoting & participating in #InternationalMECFSAwarenessDay, while strengthening our long-standing commitment to advancing research.
NCNED welcomes Rachael Davis, a third-year Bachelor of Pharmacy (Honours) student, who will be completing her dissertation with our team. Her project will investigate how medications of interest affect NK cells in cell culture & exploring mechanisms....
NCNED welcomes Samara Melray for her Master's research project investigating the effects of neuropeptides on natural killer (NK) cells of individuals living with #MECFS & #LongCOVID, focusing on characterising the effects of PACAP & VIP neuropeptides & the surface expression.
NCNED researcher Dr Etianne Sasso has recently received the PhD Candidate of the Year 2025 Award from the School of Pharmacy & Medical Sciences at #GriffithUniversity. Recognised for her research on ion channel dysfunction in #MECFS, #LongCOVID & #GWI. Proud moment for the team!
On this International #longCOVID Awareness Day, the NCNED Team acknowledges the ongoing challenges faced by individuals living with #longCOVID. As Australia’s leading research centre focused on chronic multi-system illnesses, we remain committed to improving healthcare & outcomes
PhD student Ms Maira Inderyas, together with the NCNED Researchers, has published an important neuroimaging study - please see the link below:
https://t.co/Z2cFs5jbHg
New:
26-minute radio interview on ABC (Australian national radio)
https://t.co/MCIhZ8b0Ik
Haven't listened so far. Not familiar with Dr Smith but Professor Marshall-Gradisnik @SonyaGradisnik of NCNED @NCNEDResearch should be good
#MEcfs#CFS
New Australian (NCNED) ME Research UK-funded research:
Distinct functional connectivity patterns in Myalgic Encephalomyelitis and long COVID patients during cognitive fatigue
https://t.co/936RBNoOcp
#MEcfs#LongCovid@NCNEDResearch@SonyaGradisnik
News Release (from NCNED @NCNEDResearch in Australia) 12-Jan-2026
New research confirms people with ME/CFS have a consistent faulty cellular structure
https://t.co/TOprys6DAj
#MEcfs#PwME
The NCNED team is back! We are back in the lab today for a bigger and stronger 2026 for you. We look forward to continuing our research studies into the pathomechanisms of #MECFS, #longCovid & #GWI & investigating new treatments & care pathways to improve patient health outcomes
Sustained illness burden over time among Australians with ME/chronic fatigue syndrome
https://t.co/1JzuUs3K4K
"These consistent, profound impairments emphasise the need for improved access to disability & social support services for pwME/CFS in Australia through policy reform"
Merry Christmas & a happy, safe & healthy New Year to all our supporters! NCNED would like to thank all of the volunteers, sponsors & donors for their wonderful support & participation in our #MECFS, #longCOVID & #GWI research studies during 2025. See you all in 2026!
Dr Kiran Thapaliya & NCNED Researchers have just published an important neuroimaging paper on the “Altered brain tissue microstructure and neurochemical profiles in #LongCOVID and recovered COVID-19 individuals: A multimodal MRI study.” Please see link: https://t.co/q8JRNvSbc1
The NCNED is pleased to release the latest edition of our December newsletter (please see below).
Please feel free to distribute this newsletter to people you think may be interested and encourage them to contact us if we can assist them in any way. #GriffithUni, #GriffithHealth
NCNED researcher, Dr Etianne Sasso, was recently interviewed by Dylan Murphy for Health Rising & Phoenix Rising regarding her work at NCNED & her publication: LDN restored TRPM3 ion channel function in NK cells from #LongCovid patients. #GriffithUni, #GriffithHealth, #MECFS
Low Dose Naltrexone (LDN) for the treatment of people with ME: A Conversation with Dr Etianne Sasso,
Dr Sasso is from NCNED (in Australia), who are recruiting for an #LongCovid LDN trial & will soon be recruiting for a #MEcfs LDN trial
https://t.co/PTfPemnzqf